| Evidence of escape of SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera D Zhou, W Dejnirattisai, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ... Cell 184 (9), 2348-2361. e6, 2021 | 1196 | 2021 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 1035 | 2022 |
| Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum C Liu, HM Ginn, W Dejnirattisai, P Supasa, B Wang, A Tuekprakhon, ... Cell 184 (16), 4220-4236. e13, 2021 | 807 | 2021 |
| Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ... Cell 185 (14), 2422-2433. e13, 2022 | 698 | 2022 |
| Antibody evasion by the P. 1 strain of SARS-CoV-2 W Dejnirattisai, D Zhou, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ... Cell 184 (11), 2939-2954. e9, 2021 | 689 | 2021 |
| Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 J Huo, A Le Bas, RR Ruza, HME Duyvesteyn, H Mikolajek, T Malinauskas, ... Nature structural & molecular biology 27 (9), 846-854, 2020 | 536 | 2020 |
| Reduced neutralization of SARS-CoV-2 B. 1.1. 7 variant by convalescent and vaccine sera P Supasa, D Zhou, W Dejnirattisai, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ... Cell 184 (8), 2201-2211. e7, 2021 | 526 | 2021 |
| Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike J Huo, Y Zhao, J Ren, D Zhou, H Duyvesteyn, H Ginn, L Carrique, ... Cell Host & Microbe 28 (3), 445–454, 2020 | 396 | 2020 |
| The antigenic anatomy of SARS-CoV-2 receptor binding domain W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn, P Supasa, JB Case, ... Cell 184 (8), 2183-2200.e22, 2021 | 389 | 2021 |
| Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient D Zhou, HME Duyvesteyn, CP Chen, CG Huang, TH Chen, SR Shih, ... Nature structural & molecular biology 27 (10), 950-958, 2020 | 309 | 2020 |
| Potent cross-reactive antibodies following Omicron breakthrough in vaccinees R Nutalai, D Zhou, A Tuekprakhon, HM Ginn, P Supasa, C Liu, J Huo, ... Cell 185 (12), 2116–2131. e18, 2022 | 155 | 2022 |
| Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2 D Zhou, Y Zhao, A Kotecha, EE Fry, JT Kelly, X Wang, Z Rao, ... Nature microbiology 4 (3), 414-419, 2018 | 101 | 2018 |
| The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants C Liu, D Zhou, R Nutalai, HME Duyvesteyn, A Tuekprakhon, HM Ginn, ... Cell Host & Microbe 30 (1), 53-68. e12, 2022 | 63 | 2022 |
| A delicate balance between antibody evasion and ACE2 affinity for Omicron BA. 2.75 J Huo, A Dijokaite-Guraliuc, C Liu, D Zhou, HM Ginn, R Das, P Supasa, ... Cell Reports 42 (1), 2023 | 52 | 2023 |
| Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10 Y Zhao, D Zhou, T Ni, D Karia, A Kotecha, X Wang, Z Rao, EY Jones, ... Nature communications 11 (1), 38, 2020 | 50 | 2020 |
| Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy M Ragonnet-Cronin, R Nutalai, J Huo, A Dijokaite-Guraliuc, R Das, ... Nature Communications 14 (1), 3334, 2023 | 36 | 2023 |
| Atomic structure of the Epstein-Barr virus portal C Machón, M Fàbrega-Ferrer, D Zhou, A Cuervo, JL Carrascosa, DI Stuart, ... Nature Communications 10 (1), 3891, 2019 | 34 | 2019 |
| Rapid escape of new SARS-CoV-2 Omicron variants from BA. 2-directed antibody responses A Dijokaite-Guraliuc, R Das, D Zhou, HM Ginn, C Liu, HME Duyvesteyn, ... Cell reports 42 (4), 2023 | 25 | 2023 |
| Broadly neutralizing antibodies against COVID-19 D Zhou, J Ren, EE Fry, DI Stuart Current Opinion in Virology 61, 101332, 2023 | 22 | 2023 |
| The SARS-CoV-2 Spike harbours a lipid binding pocket which modulates stability of the prefusion trimer L Carrique, HME Duyvesteyn, T Malinauskas, Y Zhao, J Ren, D Zhou, ... BioRxiv, 2020.08. 13.249177, 2020 | 17 | 2020 |